메뉴 건너뛰기




Volumn 35, Issue 4, 2000, Pages 523-530

AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT(2A) receptors and prevents the laurate-induced peripheral vascular lesion in rats

Author keywords

5 HT2 receptor antagonist; AT 1015; Peripheral vascular disease; Platelet aggregation; Serotonin; Vasoconstriction

Indexed keywords

BERAPROST; CILOSTAZOL; KETANSERIN; N [2 [4 (5H DIBENZO[A,D]CYCLOHEPTEN 5 YLIDENE)PIPERIDINO]ETHYL] 1 FORMYL 4 PIPERIDINECARBOXYLAMIDE; N [2 [4 (5H DIBENZO[A,D]CYCLOHEPTEN 5 YLIDENE)PIPERIDINO]ETHYL] 1 FORMYLISONIPECOTAMIDE; SARPOGRELATE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

EID: 0034110915     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200004000-00002     Document Type: Article
Times cited : (31)

References (3)
  • 3
    • 0021875802 scopus 로고
    • Platelet-mediated vascular permeability in the rat: A predominant role for 5-hydroxytryptamine
    • De Clerck F, Van Gorp L, Beetens J, Reneman RS. Platelet-mediated vascular permeability in the rat: a predominant role for 5-hydroxytryptamine. Thromb Res 1985;38:321-39.
    • (1985) Thromb Res , vol.38 , pp. 321-339
    • De Clerck, F.1    Van Gorp, L.2    Beetens, J.3    Reneman, R.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.